Gilead Sciences Inc. CEO Daniel O'Day's compensation rose 4.8% last year to $23.7 million — roughly $97 for every buck made ...
1d
The Marion Star on MSN2025 boys track preview: Mount Gilead using its numbers, depth, talent for title runsHere is an overview of the Marion area's boys track season before it starts this weekend. See who looks strong for 2025.
Gilead Sciences Inc. closed 10.06% short of its 52-week high of $119.96, which the company achieved on March 10th.
The iconic dystopian series The Handmaid’s Tale is making its highly anticipated return for its sixth and final season, and fans are buzzing with excitement. After eight years of exploring the ...
Investors with a lot of money to spend have taken a bearish stance on Gilead Sciences GILD. And retail traders should know.
Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the steadily upward trajectory of the company since ...
Rowan Blanchard, known for her role in Girl Meets World, is set to make waves as part of the cast in Hulu's upcoming sequel to The Handmaid's Tale, titled The Testaments. This exciting announcement ...
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target lifted by stock analysts at JPMorgan Chase & Co. from ...
News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top ...
This new reality competition series, hosted by "Barbie" and "Shang-Chi" star Simu Liu, pits 20 reality TV personalities ...
As The Handmaid's Tale gets ready to stream its final season, Samira Wiley reveals to TooFab what it felt like for Moira to ...
Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Gilead Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results